These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26110379)

  • 1. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.
    Su YJ; Yu J; Huang YQ; Yang J
    Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.
    Takayama K; Inoue S
    Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine prostate cancer: long noncoding RNAs to treat an incurable cancer - an interview with Dr Francesco Crea.
    Crea F
    Epigenomics; 2019 Oct; 11(13):1461-1462. PubMed ID: 31536382
    [No Abstract]   [Full Text] [Related]  

  • 8. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of long non-coding RNA GLIDR in prostate cancer.
    Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
    Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of prostate cancer 2016.
    Reiter RE
    Scand J Clin Lab Invest Suppl; 2016; 245():S54-9. PubMed ID: 27533326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.
    Cui W; Qian Y; Zhou X; Lin Y; Jiang J; Chen J; Zhao Z; Shen B
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S3. PubMed ID: 26100580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
    Crea F; Venalainen E; Ci X; Cheng H; Pikor L; Parolia A; Xue H; Nur Saidy NR; Lin D; Lam W; Collins C; Wang Y
    Epigenomics; 2016 May; 8(5):721-31. PubMed ID: 27096814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.
    Mehra R; Shi Y; Udager AM; Prensner JR; Sahu A; Iyer MK; Siddiqui J; Cao X; Wei J; Jiang H; Feng FY; Chinnaiyan AM
    Neoplasia; 2014 Dec; 16(12):1121-7. PubMed ID: 25499224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA: "LNCs" to cancer.
    Sültmann H; Diederichs S
    Eur Urol; 2014 Jun; 65(6):1152-3. PubMed ID: 24508069
    [No Abstract]   [Full Text] [Related]  

  • 20. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.